INVA

Innoviva owns a portfolio of medicines and receives royalties when other companies sell them. These drugs treat respiratory conditions like asthma and chronic obstructive pulmonary disease, as well as serious bacterial infections and septic shock. The company also has partnerships to develop new treatments, including experimental bacteriophage therapies that use viruses to fight infections.